The Metrohealth System

The Metrohealth System was paid $574.13M by Medicaid between Jan 2018 and Dec 2024, across 1117 billing codes. Its largest line is G0463, Hospital outpatient clinic visit for assessment and management of a patient — 41% of everything it billed.

Compared with peers

Next to other General Acute Care Hospital providers in Ohio

Rank by total paid#2 of 101

Median peer was paid$22.32M

This provider vs. median26×

Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.

Box 24A · Dates of service

Paid by month

Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider

By year, as a table

Year	Claims	Paid
2018	1,365,335	$62.22M
2019	1,345,872	$62.80M
2020	1,054,273	$74.91M
2021	1,128,956	$68.42M
2022	1,267,044	$70.75M
2023	2,678,260	$135.04M
2024incomplete	2,121,329	$100.00M

Box 24 · Service lines

What it billed for

Code	Service	Share	Claims	Bene. records	Paid
G0463	Hospital outpatient clinic visit for assessment and management of a patient	41%	2,149,204	1,815,709	$233.87M
99285	Emergency room visit (most serious)Emergency department visit for the evaluation and management, high severity with immediate threat to life	5.3%	165,456	131,113	$30.49M
99284	Emergency room visit (serious)Emergency department visit for the evaluation and management, high severity	4.8%	184,477	163,809	$27.63M
99283	Emergency room visit (moderate)Emergency department visit for the evaluation and management, moderate severity	3.6%	158,585	146,739	$20.56M
96361	Intravenous infusion, hydration; each additional hour	2.7%	47,683	37,157	$15.22M
99392	Periodic comprehensive preventive medicine reevaluation, established patient, early childhood (1-4 years)	1.3%	62,120	57,687	$7.38M
99391	Periodic comprehensive preventive medicine reevaluation, established patient, infant (under 1 year)	1.2%	58,861	51,766	$6.81M
J9271	Injection, pembrolizumab, 1 mg	1.2%	1,014	589	$6.77M
97110	Therapeutic procedure, each 15 minutes; therapeutic exercises to develop strength and endurance, flexibility and range of motion	1.2%	80,475	38,505	$6.70M
90791	Psychiatric diagnostic evaluationPsychiatric diagnostic evaluation	1.1%	26,831	24,981	$6.07M
U0003	Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r	1.0%	28,258	26,633	$5.97M
99393	Periodic comprehensive preventive medicine reevaluation, established patient, late childhood (5-11 years)	1.0%	51,529	47,683	$5.94M

1105 more codes

92014	Ophthalmological services: medical examination and evaluation, comprehensive, established patient	1.0%	72,506	$5.93M
80048	Basic metabolic panel (calcium, ionized)	<1%	423,829	$4.28M
74177	Computed tomography, abdomen and pelvis; with contrast material	<1%	13,572	$4.21M
95810	Polysomnography; sleep staging with 4 or more additional parameters	<1%	5,299	$4.12M
99394	Periodic comprehensive preventive medicine reevaluation, established patient, adolescent (12-17 years)	<1%	36,433	$4.11M
90834	Psychotherapy session, about 45 minutes	<1%	30,573	$4.09M
93306	Echocardiography, transthoracic, real-time with image documentation, with and without Doppler, complete	<1%	11,665	$3.80M
99395	Periodic comprehensive preventive medicine reevaluation, established patient, 18-39 years	<1%	30,874	$3.72M
94640	Pressurized or nonpressurized inhalation treatment for acute airway obstruction	<1%	25,330	$3.53M
70450	Computed tomography, head or brain; without contrast material	<1%	15,154	$3.52M
96365	Intravenous infusion, for therapy, prophylaxis, or diagnosis; initial, up to 1 hour	<1%	18,870	$3.40M
H0015	Alcohol and/or drug services; intensive outpatient (treatment program that operates at least 3 hours/day and at least 3 days/week and is based on an individualized treatment plan), including assessment, counseling; crisis intervention, and activity therapies or education	<1%	22,250	$3.20M
20610		<1%	17,754	$2.85M
G0378	Hospital observation service, per hour	<1%	39,164	$2.64M
90832	Psychotherapy session, about 30 minutes	<1%	23,515	$2.51M
92551		<1%	28,447	$2.40M
99396	Periodic comprehensive preventive medicine reevaluation, established patient, 40-64 years	<1%	19,809	$2.31M
99213	Doctor's office visit, returning patient (routine)	<1%	17,509	$2.23M
76816	Ultrasound, pregnant uterus, real time with image documentation, follow-up	<1%	19,596	$2.18M
90837	Psychotherapy session, about an hour	<1%	15,888	$2.13M
96366	Intravenous infusion, for therapy, prophylaxis, or diagnosis; each additional hour	<1%	7,820	$2.12M
90677		<1%	17,049	$1.96M
99281	Emergency department visit for the evaluation and management, self-limited or minor	<1%	13,386	$1.95M
43239	Esophagogastroduodenoscopy, flexible, transoral; with biopsy, single or multiple	<1%	3,796	$1.90M
80307	Drug test(s), presumptive, any number of drug classes; immunoassay	<1%	80,923	$1.88M
96413	Chemotherapy administration, intravenous infusion; up to 1 hour, single or initial substance	<1%	14,663	$1.80M
99214	Doctor's office visit, returning patient (more involved)	<1%	12,979	$1.69M
99211	Office or other outpatient visit for the evaluation and management of an established patient, minimal severity	<1%	11,238	$1.65M
76856	Ultrasound, pelvic (nonobstetric), real time with image documentation; complete	<1%	8,672	$1.62M
H2019	Therapeutic behavioral services, billed per 15 minutes	<1%	20,764	$1.57M
99212	Office or other outpatient visit for the evaluation and management of an established patient, straightforward	<1%	10,291	$1.46M
76801		<1%	10,818	$1.39M
90792	Psychiatric diagnostic evaluation with medical services	<1%	5,485	$1.37M
D7140	Extraction, erupted tooth or exposed root	<1%	1,395	$1.37M
95811		<1%	2,142	$1.35M
87591	Infectious agent detection by nucleic acid; Neisseria gonorrhoeae, amplified probe	<1%	146,084	$1.35M
G0121	Colorectal cancer screening; colonoscopy on individual not meeting criteria for high risk	<1%	1,952	$1.31M
76819	Fetal biophysical profile; without non-stress testing	<1%	14,806	$1.24M
77386		<1%	3,751	$1.24M
45385	Colonoscopy, flexible; with removal of tumor(s), polyp(s), or other lesion(s)	<1%	1,969	$1.23M
J2315	Injection, naltrexone, depot form, 1 mg	<1%	986	$1.23M
J1050	Injection, medroxyprogesterone acetate, 1 mg	<1%	17,539	$1.22M
96110	Developmental screening, with scoring and documentation, per standardized instrument	<1%	5,249	$1.19M
J7307	Etonogestrel (contraceptive) implant system, including implant and supplies	<1%	1,041	$1.17M
90853	Group psychotherapy (other than of a multiple-family group)	<1%	10,349	$1.17M
45380	Colonoscopy, flexible; with biopsy, single or multiple	<1%	2,341	$1.15M
96360	Intravenous infusion, hydration; initial, 31 minutes to 1 hour	<1%	8,031	$1.13M
97112	Therapeutic procedure, each 15 minutes; neuromuscular reeducation of movement, balance, coordination	<1%	17,412	$1.10M
92507	Treatment of speech, language, voice, communication, and/or auditory processing disorder	<1%	11,746	$1.10M
95886		<1%	3,836	$1.09M
90686		<1%	95,830	$1.08M
59025	Fetal non-stress test	<1%	6,073	$1.06M
80076		<1%	172,945	$1.05M
97803		<1%	10,197	$1.04M
80061	Lipid panel	<1%	114,878	$1.01M
95813		<1%	1,215	$997K
74176	Computed tomography, abdomen and pelvis; without contrast material	<1%	3,067	$977K
76811	Ultrasound, pregnant uterus, real time with image documentation, fetal and maternal evaluation, detailed	<1%	7,775	$957K
11056		<1%	6,385	$947K
76705	Ultrasound, abdominal, real time with image documentation; limited	<1%	8,502	$931K
92012	Ophthalmological services: medical examination and evaluation, intermediate, established patient	<1%	13,412	$882K
52000		<1%	1,199	$879K
77063	Screening digital breast tomosynthesis, bilateral	<1%	17,159	$868K
11102		<1%	1,982	$861K
97530	Therapeutic activities, direct patient contact, each 15 minutes	<1%	15,418	$832K
71275	Computed tomographic angiography, chest, with contrast material	<1%	2,473	$784K
64483		<1%	1,431	$780K
83036	Hemoglobin; glycosylated (A1C)	<1%	138,400	$778K
90651		<1%	19,992	$773K
36415	Collection of venous blood by venipuncture	<1%	643,021	$755K
96160		<1%	5,546	$749K
87491	Infectious agent detection by nucleic acid; Chlamydia trachomatis, amplified probe	<1%	146,496	$742K
31575		<1%	2,970	$731K
36000		<1%	8,965	$722K
87636	Infectious agent detection by nucleic acid; SARS-CoV-2 and influenza virus types A and B	<1%	35,355	$670K
70498		<1%	2,108	$669K
G0451	Development testing, with interpretation and report, per standardized instrument form	<1%	11,701	$661K
90750		<1%	3,618	$645K
90833	Psychotherapy, 30 minutes with patient when performed with an E&M service (add-on)	<1%	5,769	$638K
87631		<1%	5,417	$601K
11721		<1%	21,424	$600K
90471	Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine	<1%	177,809	$599K
78815	Positron emission tomography (PET) for limited area imaging	<1%	910	$584K
J7297	Levonorgestrel-releasing intrauterine contraceptive system (liletta), 52 mg	<1%	851	$574K
64493		<1%	808	$569K
82306	Vitamin D; 25 hydroxy, includes fraction(s), if performed	<1%	47,005	$569K
17110		<1%	2,898	$568K
78452	Myocardial perfusion imaging, tomographic (SPECT); multiple studies at rest and/or stress	<1%	1,252	$567K
84443	Thyroid stimulating hormone (TSH)	<1%	74,921	$564K
76642		<1%	4,784	$560K
92557		<1%	7,785	$556K
95806		<1%	1,052	$555K
66984	Extracapsular cataract removal with insertion of intraocular lens prosthesis	<1%	917	$551K
87661	Infectious agent detection by nucleic acid; Trichomonas vaginalis, amplified probe	<1%	104,956	$533K
96127		<1%	4,811	$523K
43235		<1%	1,034	$502K
70553	Magnetic resonance imaging, brain; without contrast material, followed by contrast material and further sequences	<1%	1,721	$497K
96415		<1%	1,949	$494K
42820	Tonsillectomy and adenoidectomy; younger than age 12	<1%	400	$488K
97162		<1%	8,765	$484K
97802		<1%	4,657	$484K
86850		<1%	23,276	$475K
85025	Blood count; complete (CBC), automated, and automated differential WBC count	<1%	239,364	$467K
77412		<1%	3,590	$463K
J0585	Injection, onabotulinumtoxina, 1 unit	<1%	775	$449K
27447		<1%	197	$444K
76813		<1%	5,975	$439K
67028	Intravitreal injection of a pharmacologic agent	<1%	2,914	$432K
T1002	Rn services, up to 15 minutes	<1%	5,964	$426K
71046	Radiologic examination, chest; 2 views	<1%	59,005	$419K
76770		<1%	2,329	$417K
J0561	Injection, penicillin g benzathine, 100,000 units	<1%	1,215	$415K
76805	Ultrasound, pregnant uterus, real time with image documentation, fetal and maternal evaluation	<1%	3,463	$411K
H0036	Community psychiatric support and treatment, per 15 minutes	<1%	9,586	$403K
81220	CFTR (cystic fibrosis transmembrane conductance regulator) gene analysis; common variants	<1%	1,652	$388K
70491		<1%	1,188	$383K
85027		<1%	120,964	$380K
71271		<1%	2,031	$380K
93017		<1%	4,270	$379K
11900		<1%	1,836	$370K
92567		<1%	13,001	$369K
95117		<1%	10,453	$366K
83655		<1%	25,361	$365K
27130		<1%	83	$362K
91200		<1%	2,940	$358K
77336		<1%	3,657	$354K
97140	Manual therapy techniques, each 15 minutes (e.g., mobilization/manipulation, manual lymphatic drainage)	<1%	12,022	$353K
11104		<1%	798	$345K
11055		<1%	2,427	$342K
57454		<1%	1,069	$339K
76821		<1%	5,657	$336K
59430		<1%	3,282	$334K
41899	Unlisted procedure, dentoalveolar structures	<1%	594	$334K
76820		<1%	5,618	$332K
D2930	Prefabricated stainless steel crown - primary tooth	<1%	414	$328K
20611		<1%	956	$327K
90620		<1%	8,603	$327K
86900		<1%	27,106	$324K
J0475	Injection, baclofen, 10 mg	<1%	460	$319K
92134		<1%	8,452	$319K
69436	Tympanostomy (requiring insertion of ventilating tube), general anesthesia	<1%	227	$318K
J9173	Injection, durvalumab, 10 mg	<1%	125	$317K
93005	Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report	<1%	149,169	$316K
82607		<1%	33,838	$309K
90648		<1%	36,592	$308K
J0897	Injection, denosumab, 1 mg	<1%	339	$308K
97166		<1%	4,281	$306K
95004	Percutaneous tests with allergenic extracts, immediate type reaction	<1%	4,149	$303K
97116		<1%	7,489	$301K
20550		<1%	1,691	$301K
76536		<1%	2,503	$300K
93320		<1%	1,800	$300K
J2357	Injection, omalizumab, 5 mg	<1%	301	$299K
72148	Magnetic resonance imaging, lumbar spine; without contrast material	<1%	1,785	$293K
71260	Computed tomography, thorax, diagnostic; with contrast material	<1%	5,799	$292K
11042	Debridement, subcutaneous tissue (includes epidermis, dermis, and subcutaneous tissue); first 20 sq cm	<1%	1,867	$289K
90670		<1%	35,373	$279K
94060		<1%	7,463	$272K
19083		<1%	317	$272K
H0005	Alcohol and/or drug services; group counseling by a clinician	<1%	4,603	$271K
93970		<1%	1,662	$270K
G0476	Infectious agent detection by nucleic acid (dna or rna); human papillomavirus (hpv), high-risk types (e.g., 16, 18, 31, 33, 35, 39, 45, 51, 52, 56, 58, 59, 68) for cervical cancer screening, must be performed in addition to pap test	<1%	29,410	$267K
71250		<1%	2,533	$266K
66982		<1%	360	$262K
76830	Ultrasound, transvaginal	<1%	5,918	$258K
58661		<1%	103	$251K
62323		<1%	570	$250K
77290		<1%	481	$246K
74183		<1%	956	$246K
93923		<1%	2,389	$240K
86701		<1%	42,788	$237K
90715		<1%	17,430	$236K
96112		<1%	754	$235K
0001A		<1%	5,834	$231K
36430		<1%	1,129	$229K
P9016	Red blood cells, leukocytes reduced, each unit	<1%	809	$228K
86780		<1%	32,063	$228K
84484		<1%	55,107	$228K
94010		<1%	2,587	$227K
96372	Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular	<1%	112,090	$225K
64415		<1%	569	$224K
73560		<1%	9,773	$221K
93303	Transthoracic echocardiography for congenital cardiac anomalies, follow-up or limited study	<1%	545	$218K
64721		<1%	333	$218K
J0741	Injection, cabotegravir and rilpivirine, 2mg/3mg	<1%	226	$217K
93971		<1%	2,697	$215K
11750		<1%	487	$214K
73721	Magnetic resonance imaging, any joint of lower extremity; without contrast material	<1%	847	$213K
93325		<1%	2,308	$206K
C1776	Joint device (implantable)	<1%	708	$205K
12001		<1%	1,126	$204K
97165		<1%	2,301	$204K
90633		<1%	21,841	$202K
93308		<1%	631	$199K
11100		<1%	521	$199K
82728		<1%	21,265	$195K
97535	Self-care/home management training, each 15 minutes	<1%	5,489	$195K
58558		<1%	147	$194K
92523		<1%	2,295	$191K
87536		<1%	8,739	$190K
70551	Magnetic resonance imaging, brain; without contrast material	<1%	973	$189K
76817	Ultrasound, pregnant uterus, real time with image documentation, transvaginal	<1%	3,333	$189K
0002A		<1%	4,639	$188K
J9217	Leuprolide acetate (for depot suspension), 7.5 mg	<1%	467	$188K
72141		<1%	1,484	$185K
87390		<1%	42,558	$183K
77067	Screening mammography, bilateral, including computer-aided detection	<1%	17,152	$180K
86803		<1%	24,193	$177K
93975		<1%	1,228	$176K
62321		<1%	415	$176K
94729		<1%	6,671	$169K
88142		<1%	18,737	$169K
94618		<1%	1,872	$168K
73630		<1%	10,556	$164K
86702		<1%	42,811	$164K
85610		<1%	49,247	$161K
84439		<1%	12,772	$161K
92083		<1%	4,415	$160K
72197		<1%	509	$156K
73610		<1%	8,823	$154K
76641		<1%	1,778	$154K
99406		<1%	6,646	$154K
70486		<1%	2,679	$154K
10005		<1%	369	$153K
94726		<1%	4,791	$152K
92133		<1%	5,277	$151K
96910		<1%	3,059	$150K
96367		<1%	2,310	$148K
90723		<1%	30,431	$146K
20526		<1%	727	$146K
97161		<1%	2,597	$145K
82274		<1%	5,623	$144K
87522	Neg quan hep c or qual rna	<1%	5,080	$143K
87902		<1%	1,059	$140K
99385		<1%	1,171	$140K
0124A		<1%	4,537	$139K
10060		<1%	716	$138K
20680		<1%	185	$138K
73030		<1%	8,007	$138K
74018		<1%	3,502	$134K
12011		<1%	708	$133K
99384		<1%	1,266	$133K
11981		<1%	600	$132K
11720		<1%	4,262	$130K
90734		<1%	15,240	$128K
92020		<1%	1,843	$127K
74178		<1%	457	$127K
99215	Doctor's office visit, returning patient (complex)	<1%	777	$126K
87086	Culture, bacterial; quantitative colony count, urine	<1%	39,269	$126K
58100		<1%	799	$125K
87798	Infectious agent detection by nucleic acid; not otherwise specified, amplified probe, each organism	<1%	9,796	$124K
99383		<1%	1,210	$124K
10061		<1%	722	$123K
95885		<1%	398	$122K
93270		<1%	1,440	$121K
73221		<1%	516	$121K
64566		<1%	239	$120K
87210		<1%	110,381	$116K
97163		<1%	1,762	$115K
83540		<1%	21,878	$114K
73130		<1%	7,905	$112K
90460	Immunization administration through 18 years of age via any route, first or only component	<1%	71,431	$112K
11982		<1%	559	$111K
12002		<1%	637	$110K
88307		<1%	1,326	$109K
72125	Computed tomography, cervical spine; without contrast material	<1%	6,302	$108K
84466		<1%	21,762	$108K
86140		<1%	17,442	$107K
90472	Immunization administration, each additional vaccine (list separately)	<1%	81,969	$107K
76882		<1%	1,056	$105K
J9022	Injection, atezolizumab, 10 mg	<1%	27	$104K
81025		<1%	145,710	$103K
86359		<1%	6,085	$102K
76815	Ultrasound, pregnant uterus, real time with image documentation, limited	<1%	2,134	$102K
87637	Infectious agent detection by nucleic acid; SARS-CoV-2, influenza, and RSV	<1%	1,910	$102K
88305	Level IV - Surgical pathology, gross and microscopic examination	<1%	32,898	$101K
58300		<1%	933	$100K
97129		<1%	2,019	$99K
86481		<1%	3,916	$99K
51700		<1%	582	$98K
J1750	Injection, iron dextran, 50 mg	<1%	1,237	$98K
31231		<1%	471	$97K
11057		<1%	655	$97K
76831		<1%	430	$96K
94664		<1%	9,151	$96K
29075		<1%	593	$94K
82570		<1%	22,229	$94K
51741		<1%	2,695	$92K
G0480	Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms (any type, single or tandem and excluding immunoassays (e.g., ia, eia, elisa, emit, fpia) and enzymatic methods (e.g., alcohol dehydrogenase)), (2) stable isotope or other universally recognized internal standards in all samples (e.g., to control for matrix effects, interferences and variations in signal strength), and (3) method or drug-specific calibration and matrix-matched quality control material (e.g., to control for instrument variations and mass spectral drift); qualitative or quantitative, all sources, includes specimen validity testing, per day; 1-7 drug class(es), including metabolite(s) if performed	<1%	7,377	$92K
H2017	Psychosocial rehabilitation, billed per 15 minutes	<1%	1,418	$91K
73700		<1%	688	$91K
D7240	Removal of impacted tooth - completely bony	<1%	121	$91K
96130		<1%	433	$90K
20600		<1%	516	$90K
72100		<1%	3,100	$89K
73110		<1%	5,704	$89K
0003A		<1%	2,483	$89K
84403		<1%	6,936	$89K
93296		<1%	4,019	$89K
90636		<1%	2,229	$88K
83735		<1%	59,658	$88K
92587		<1%	995	$87K
73502		<1%	4,633	$86K
77080		<1%	1,315	$85K
86355		<1%	3,240	$84K
84153		<1%	10,709	$84K
91320		<1%	3,238	$83K
97597		<1%	726	$83K
51798		<1%	3,765	$82K
20605		<1%	512	$82K
47562		<1%	38	$82K
Q5107	Injection, bevacizumab-awwb, biosimilar, (mvasi), 10 mg	<1%	136	$81K
72110		<1%	3,043	$81K
90680		<1%	17,969	$81K
72040		<1%	2,484	$80K
95700		<1%	574	$80K
87340		<1%	13,748	$79K
95782		<1%	101	$79K
77066	Tomosynthesis, mammo	<1%	1,800	$78K
81003		<1%	142,151	$78K
99397		<1%	974	$77K
74230		<1%	600	$77K
76870		<1%	897	$77K
77334		<1%	268	$76K
51784		<1%	459	$76K
84702		<1%	9,271	$76K
17250		<1%	489	$76K
64450		<1%	508	$76K
81001		<1%	96,180	$75K
72146		<1%	346	$74K
80348		<1%	3,256	$74K
86360		<1%	6,097	$73K
25600		<1%	230	$73K
0011A		<1%	2,139	$72K
J2506	Injection, pegfilgrastim, excludes biosimilar, 0.5 mg	<1%	145	$72K
87633	Infectious agent detection by nucleic acid, respiratory virus, 12-25 targets	<1%	860	$72K
26600		<1%	232	$72K
96374	Therapeutic, prophylactic, or diagnostic injection; intravenous push, single or initial substance	<1%	66,794	$71K
G0127	Trimming of dystrophic nails, any number	<1%	3,843	$71K
83970		<1%	5,169	$70K
V5261	Hearing aid, digital, binaural, bte	<1%	189	$69K
76857		<1%	885	$69K
86901		<1%	27,231	$69K
99386		<1%	545	$68K
93880		<1%	713	$68K
95714		<1%	94	$67K
72131		<1%	1,715	$67K
88341		<1%	1,369	$66K
58301		<1%	735	$65K
77065	Tomosynthesis, mammo	<1%	1,508	$65K
0012A		<1%	1,639	$64K
77280		<1%	433	$64K
70487		<1%	209	$64K
72050		<1%	1,862	$64K
92526		<1%	949	$64K
C1713	Anchor/screw for opposing bone-to-bone or soft tissue-to-bone (implantable)	<1%	2,715	$64K
17311		<1%	130	$62K
87081		<1%	29,822	$60K
90716		<1%	4,392	$60K
Q3014	Telehealth originating site facility fee	<1%	10,554	$60K
36561		<1%	68	$59K
97130		<1%	1,961	$59K
99382		<1%	547	$58K
J0178	Injection, aflibercept, 1 mg	<1%	59	$58K
82948		<1%	38,552	$57K
90656		<1%	6,145	$56K
70496		<1%	1,882	$56K
64615		<1%	208	$55K
V5160	Dispensing fee, binaural	<1%	315	$54K
99152		<1%	7,236	$53K
72082		<1%	1,237	$53K
86706		<1%	5,974	$53K
93246		<1%	577	$53K
73562		<1%	2,606	$53K
96416		<1%	305	$51K
82670		<1%	3,445	$51K
81329		<1%	1,032	$50K
71045	Radiologic examination, chest; single view	<1%	9,452	$50K
70480		<1%	315	$50K
26720		<1%	165	$49K
29085		<1%	364	$49K
95708		<1%	71	$48K
H0006	Alcohol and/or drug services; case management	<1%	1,521	$48K
J1756	Injection, iron sucrose, 1 mg	<1%	873	$48K
90480		<1%	3,423	$47K
92579		<1%	828	$47K
0071A		<1%	1,661	$47K
62370		<1%	624	$46K
86580		<1%	2,133	$46K
0004A		<1%	1,466	$46K
17000		<1%	399	$46K
96132		<1%	208	$45K
G0109	Diabetes outpatient self-management training services, group session (2 or more), per 30 minutes	<1%	523	$45K
95913		<1%	606	$45K
27096		<1%	106	$44K
83880		<1%	8,954	$44K
G0279	Diagnostic digital breast tomosynthesis, unilateral or bilateral (list separately in addition to 77065 or 77066)	<1%	3,277	$43K
64418		<1%	182	$43K
Q9991	Injection, buprenorphine extended-release (sublocade), less than or equal to 100 mg	<1%	79	$43K
77385		<1%	346	$43K
86357		<1%	3,240	$43K
97750		<1%	576	$43K
97763		<1%	642	$42K
99381		<1%	374	$42K
74170		<1%	160	$42K
87880	Infectious agent antigen detection by immunoassay; Streptococcus, group A	<1%	52,158	$40K
82105		<1%	5,123	$40K
82043		<1%	14,205	$40K
90696		<1%	5,395	$39K
86235		<1%	7,031	$39K
64447		<1%	348	$39K
93225		<1%	479	$39K
95816		<1%	349	$39K
93242		<1%	437	$39K
J1745	Injection, infliximab, excludes biosimilar, 10 mg	<1%	40	$39K
88360		<1%	462	$38K
97760		<1%	616	$38K
64643		<1%	100	$37K
97032		<1%	620	$37K
73080		<1%	3,081	$37K
72128		<1%	1,210	$36K
77300		<1%	114	$36K
C8929	Transthoracic echocardiography with contrast, or without contrast followed by with contrast, real-time with image documentation (2d), includes m-mode recording, when performed, complete, with spectral doppler echocardiography, and with color flow doppler echocardiography	<1%	1,222	$36K
86923		<1%	1,339	$36K
88175	Cytopathology, cervical or vaginal, any reporting system; collected in preservative fluid, automated thin layer	<1%	11,501	$35K
00170	Anesthesia for intraoral procedures, including biopsy	<1%	4,491	$35K
73590		<1%	3,081	$35K
86038		<1%	4,023	$35K
74174		<1%	482	$34K
92611		<1%	540	$34K
V5266	Battery for use in hearing device	<1%	6,138	$34K
58340		<1%	304	$34K
90710		<1%	7,442	$34K
90746		<1%	2,326	$33K
97167		<1%	390	$33K
J9202	Goserelin acetate implant, per 3.6 mg	<1%	67	$33K
S9472	Cardiac rehabilitation program, non-physician provider, per diem	<1%	492	$33K
58662		<1%	26	$33K
86592		<1%	4,004	$32K
0072A		<1%	959	$32K
95910		<1%	348	$32K
90785		<1%	3,044	$31K
64490		<1%	49	$31K
73140		<1%	2,117	$31K
11983		<1%	68	$31K
96101		<1%	206	$30K
81002		<1%	52,945	$30K
Q9967	Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml	<1%	38,410	$30K
90714		<1%	1,689	$29K
86704		<1%	3,264	$28K
85652		<1%	15,166	$28K
83718		<1%	11,083	$28K
36589		<1%	45	$27K
96375	Therapeutic injection; each additional sequential IV push	<1%	39,964	$27K
96368		<1%	1,369	$27K
82465		<1%	11,157	$26K
11730		<1%	284	$26K
77077		<1%	878	$25K
85018		<1%	5,109	$25K
73564		<1%	4,965	$25K
78264		<1%	113	$25K
90700		<1%	4,872	$24K
86225		<1%	4,050	$24K
83883		<1%	1,699	$24K
90707		<1%	4,237	$24K
C9257	Injection, bevacizumab, 0.25 mg	<1%	1,223	$24K
83020		<1%	3,411	$24K
95912		<1%	270	$23K
72070		<1%	886	$22K
77301		<1%	20	$22K
J3145	Injection, testosterone undecanoate, 1 mg	<1%	20	$22K
83615		<1%	6,193	$21K
92610		<1%	566	$21K
94727		<1%	767	$21K
95911		<1%	319	$21K
94660		<1%	215	$21K
90662		<1%	2,975	$21K
87077		<1%	7,021	$21K
96136		<1%	661	$21K
26055		<1%	34	$20K
87502	Infectious agent detection by nucleic acid, influenza virus, for multiple types or subtypes, includes all targets	<1%	870	$20K
87186		<1%	9,621	$20K
J2790	Injection, rho d immune globulin, human, full dose, 300 micrograms (1500 i.u.)	<1%	276	$20K
82040		<1%	5,500	$19K
J2791	Injection, rho(d) immune globulin (human), (rhophylac), intramuscular or intravenous, 100 iu	<1%	314	$19K
U0005	Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, cdc or non-cdc, making use of high throughput technologies, completed within 2 calendar days from date of specimen collection (list separately in addition to either hcpcs code u0003 or u0004) as described by cms-2020-01-r2	<1%	18,580	$19K
73552		<1%	1,861	$19K
82565		<1%	3,039	$19K
84460		<1%	7,684	$19K
83721		<1%	6,394	$19K
86870		<1%	566	$19K
J7323	Hyaluronan or derivative, euflexxa, for intra-articular injection, per dose	<1%	146	$19K
84100		<1%	9,340	$19K
86708		<1%	2,902	$19K
73522		<1%	772	$18K
77072		<1%	413	$18K
86160		<1%	3,745	$18K
82784		<1%	3,933	$18K
0154A		<1%	437	$18K
93922		<1%	270	$18K
J7300	Intrauterine copper contraceptive (paragard)	<1%	15	$18K
86003		<1%	2,314	$18K
55700		<1%	19	$18K
0013A		<1%	640	$18K
83001		<1%	2,257	$18K
28470		<1%	57	$18K
64642		<1%	201	$17K
84156		<1%	7,303	$17K
29405		<1%	126	$17K
73200		<1%	147	$17K
84146		<1%	1,939	$17K
82746		<1%	4,114	$17K
86762		<1%	2,863	$16K
90647		<1%	1,666	$16K
38222		<1%	17	$16K
72170		<1%	1,536	$16K
83516		<1%	1,501	$16K
27786		<1%	48	$16K
82533		<1%	940	$16K
80349		<1%	828	$15K
92250		<1%	829	$15K
97542		<1%	245	$15K
96376		<1%	5,530	$15K
87493		<1%	606	$15K
D7230		<1%	30	$15K
84481		<1%	2,132	$15K
96125		<1%	72	$15K
69210		<1%	1,566	$15K
87338		<1%	797	$15K
84450		<1%	4,606	$14K
77002		<1%	1,615	$14K
D0150	Comprehensive oral evaluation - new or established patient	<1%	153	$14K
49083		<1%	32	$14K
0111A		<1%	527	$14K
76514		<1%	627	$14K
84550		<1%	4,765	$14K
83690		<1%	25,058	$14K
99282	Emergency department visit for the evaluation and management, low to moderate severity	<1%	101	$14K
83605		<1%	10,372	$14K
0054A		<1%	898	$14K
73090		<1%	2,080	$14K
0051A		<1%	610	$13K
97035		<1%	151	$13K
84480		<1%	1,762	$13K
82077		<1%	11,916	$13K
0134A		<1%	499	$13K
64635		<1%	16	$13K
96131		<1%	231	$13K
J9045	Injection, carboplatin, 50 mg	<1%	844	$13K
72156		<1%	75	$13K
90632		<1%	1,099	$13K
87635	Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe	<1%	2,289	$12K
87088		<1%	6,217	$12K
82951		<1%	515	$12K
73620		<1%	558	$12K
75635		<1%	44	$12K
19081		<1%	13	$12K
82950		<1%	3,278	$12K
99153	Mod sedat endo service >5yrs	<1%	1,689	$12K
82550		<1%	4,992	$12K
93350		<1%	785	$11K
86735		<1%	877	$11K
G0008	Administration of influenza virus vaccine	<1%	5,320	$11K
36902		<1%	15	$11K
80164		<1%	1,221	$11K
J3471	Injection, hyaluronidase, ovine, preservative free, per 1 usp unit (up to 999 usp units)	<1%	226	$11K
93978		<1%	89	$11K
93926		<1%	138	$11K
86431		<1%	1,752	$11K
87070		<1%	4,266	$11K
D1120	Dental cleaning, child	<1%	213	$11K
84144		<1%	703	$11K
97533		<1%	164	$11K
96138		<1%	206	$10K
73660		<1%	807	$10K
84445		<1%	524	$10K
11103		<1%	189	$10K
51728		<1%	80	$10K
87517		<1%	585	$10K
80320		<1%	1,022	$10K
80365		<1%	645	$10K
72114		<1%	275	$10K
99407		<1%	385	$10K
87045		<1%	654	$10K
87046		<1%	1,307	$10K
85730		<1%	13,631	$10K
90739		<1%	788	$10K
92553		<1%	138	$10K
84165		<1%	1,950	$10K
87529		<1%	3,153	$10K
90681		<1%	1,209	$9K
76883		<1%	104	$9K
73060		<1%	1,260	$9K
86787		<1%	1,266	$9K
26750		<1%	27	$9K
C1889	Implantable/insertable device, not otherwise classified	<1%	6,669	$9K
J2426	Injection, paliperidone palmitate extended release (invega sustenna), 1 mg	<1%	56	$9K
90685		<1%	1,069	$9K
84630		<1%	955	$9K
91010		<1%	41	$9K
87389	Infectious agent antigen detection by immunoassay technique, HIV-1 antigen with HIV-1 and HIV-2 antibodies	<1%	3,619	$9K
86376		<1%	984	$9K
82378		<1%	757	$9K
Q0162	Ondansetron 1 mg, oral, fda approved prescription anti-emetic, for use as a complete therapeutic substitute for an iv anti-emetic at the time of chemotherapy treatment, not to exceed a 48 hour dosage regimen	<1%	6,788	$9K
72190		<1%	325	$9K
82947		<1%	3,037	$9K
J1885	Injection, ketorolac tromethamine, per 15 mg	<1%	68,774	$8K
77333		<1%	78	$8K
95012		<1%	772	$8K
0052A		<1%	239	$8K
86765		<1%	876	$8K
87427		<1%	1,211	$8K
J8501	Aprepitant, oral, 5 mg	<1%	752	$8K
J7120	Ringers lactate infusion, up to 1000 cc	<1%	36,738	$8K
C9153	Injection, amisulpride, 1 mg	<1%	67	$8K
Q9957	Injection, perflutren lipid microspheres, per ml	<1%	3,713	$8K
J2704	Injection, propofol, 10 mg	<1%	60,192	$8K
12032		<1%	202	$8K
83002		<1%	1,189	$8K
12013		<1%	46	$8K
87147		<1%	6,191	$8K
73000		<1%	536	$8K
82952		<1%	495	$8K
83520		<1%	747	$7K
0112A		<1%	215	$7K
85045		<1%	3,306	$7K
29065		<1%	43	$7K
92136		<1%	282	$7K
82627		<1%	711	$7K
82247		<1%	1,742	$7K
J0185	Injection, aprepitant, 1 mg	<1%	72	$7K
90678		<1%	769	$7K
82525		<1%	749	$7K
86304		<1%	600	$7K
93299		<1%	296	$7K
77338		<1%	20	$7K
70360		<1%	317	$7K
83986		<1%	839	$7K
84270		<1%	888	$7K
D7210	Extraction, erupted tooth requiring removal of bone and/or sectioning of tooth	<1%	18	$7K
36591		<1%	936	$6K
86695		<1%	912	$6K
94770		<1%	82	$6K
93298		<1%	289	$6K
84425		<1%	993	$6K
J7030	Infusion, normal saline solution , 1000 cc	<1%	58,518	$6K
J7321	Hyaluronan or derivative, hyalgan, supartz or visco-3, for intra-articular injection, per dose	<1%	94	$6K
92582		<1%	153	$6K
86334		<1%	875	$6K
82677		<1%	748	$6K
87486		<1%	1,209	$6K
83993		<1%	344	$6K
84681		<1%	833	$6K
70250		<1%	108	$6K
88304		<1%	2,818	$6K
80177		<1%	1,214	$6K
86593		<1%	828	$6K
J0574	Buprenorphine/naloxone, oral, greater than 6 mg, but less than or equal to 10 mg buprenorphine	<1%	960	$6K
J1170	Injection, hydromorphone, up to 4 mg	<1%	10,238	$6K
51729		<1%	128	$6K
86255		<1%	798	$6K
86200		<1%	1,001	$6K
83010		<1%	1,113	$5K
74019		<1%	251	$5K
87205		<1%	4,154	$5K
92950		<1%	15	$5K
0164A		<1%	134	$5K
87328		<1%	507	$5K
86696		<1%	912	$5K
72158		<1%	52	$5K
82977		<1%	1,133	$5K
71101		<1%	419	$5K
86341		<1%	583	$5K
87449		<1%	709	$5K
85378		<1%	2,810	$5K
D0120	Dental checkup, returning patient	<1%	125	$5K
J7325	Hyaluronan or derivative, synvisc or synvisc-one, for intra-articular injection, 1 mg	<1%	85	$5K
82172		<1%	597	$5K
64454		<1%	23	$5K
36592		<1%	4,740	$5K
96402		<1%	1,107	$5K
86709		<1%	543	$5K
82785		<1%	828	$5K
65855		<1%	46	$5K
80178		<1%	378	$5K
73650		<1%	382	$4K
77073		<1%	252	$4K
31579		<1%	13	$4K
82310		<1%	642	$4K
96133		<1%	201	$4K
Q0114	Fern test	<1%	773	$4K
88112		<1%	847	$4K
84155		<1%	1,977	$4K
87634		<1%	1,001	$4K
90732		<1%	399	$4K
87329		<1%	507	$4K
A7034	Nasal interface (mask or cannula type) used with positive airway pressure device, with or without head strap	<1%	81	$4K
J1650	Injection, enoxaparin sodium, 10 mg	<1%	6,056	$4K
72072		<1%	231	$4K
J2543	Injection, piperacillin sodium/tazobactam sodium, 1 gram/0.125 grams (1.125 grams)	<1%	1,348	$4K
86364		<1%	419	$4K
J0696	Injection, ceftriaxone sodium, per 250 mg	<1%	6,449	$4K
99457		<1%	40	$4K
86800		<1%	364	$4K
83013		<1%	79	$4K
93925		<1%	54	$4K
64445		<1%	14	$4K
84132		<1%	1,984	$4K
87040		<1%	2,479	$4K
A4648	Tissue marker, implantable, any type, each	<1%	648	$3K
83921		<1%	630	$3K
86705		<1%	413	$3K
J3490	Unclassified drugs	<1%	548	$3K
J3260	Injection, tobramycin sulfate, up to 80 mg	<1%	189	$3K
00731		<1%	2,671	$3K
J3420	Injection, vitamin b-12 cyanocobalamin, up to 1000 mcg	<1%	5,640	$3K
90381		<1%	463	$3K
93280		<1%	230	$3K
82610		<1%	360	$3K
00902		<1%	239	$3K
82803		<1%	2,377	$3K
J0476	Injection, baclofen, 50 mcg for intrathecal trial	<1%	53	$3K
20553		<1%	30	$3K
92285		<1%	40	$3K
00840		<1%	1,049	$3K
90380		<1%	416	$3K
J1642	Injection, heparin sodium, (heparin lock flush), per 10 units	<1%	3,676	$3K
0031A		<1%	82	$3K
85660		<1%	948	$3K
82010		<1%	1,786	$3K
86336		<1%	777	$3K
96113		<1%	304	$3K
96417		<1%	1,651	$3K
78306		<1%	12	$3K
98926		<1%	58	$3K
88342		<1%	2,722	$3K
J3489	Injection, zoledronic acid, 1 mg	<1%	226	$3K
87581		<1%	1,214	$3K
86308		<1%	558	$3K
J3475	Injection, magnesium sulfate, per 500 mg	<1%	6,787	$3K
69209		<1%	2,413	$3K
90474		<1%	7,283	$3K
82330		<1%	857	$3K
72220		<1%	155	$3K
76512		<1%	18	$3K
99201		<1%	15	$3K
94761		<1%	52,244	$3K
87206		<1%	1,170	$3K
90672		<1%	295	$3K
29705		<1%	14	$3K
92004	Ophthalmological services: medical examination and evaluation, comprehensive, new patient	<1%	26	$3K
97804		<1%	20	$3K
92550		<1%	118	$3K
87563		<1%	951	$3K
J9171	Injection, docetaxel, 1 mg	<1%	44	$3K
01992		<1%	847	$2K
81050		<1%	310	$2K
87109		<1%	542	$2K
84166		<1%	341	$2K
J7040	Infusion, normal saline solution, sterile (500 ml = 1 unit)	<1%	25,179	$2K
90744		<1%	453	$2K
72192		<1%	33	$2K
29580		<1%	21	$2K
86147		<1%	292	$2K
90713		<1%	446	$2K
17003		<1%	107	$2K
83521		<1%	435	$2K
J0881	Injection, darbepoetin alfa, 1 microgram (non-esrd use)	<1%	29	$2K
J3372	Injection, vancomycin hcl (xellia), not therapeutically equivalent to j3370, 500 mg	<1%	1,064	$2K
29515		<1%	803	$2K
00940		<1%	95	$2K
J0703	Injection, cefepime hydrochloride (b braun), not therapeutically equivalent to maxipime, 500 mg	<1%	511	$2K
20552		<1%	20	$2K
00400		<1%	703	$2K
96156		<1%	14	$2K
96401		<1%	225	$2K
86665		<1%	345	$2K
97164		<1%	21	$2K
96523		<1%	85	$2K
00811		<1%	1,389	$2K
V5014	Repair/modification of a hearing aid	<1%	57	$2K
94760		<1%	41,581	$2K
90698		<1%	247	$2K
83525		<1%	122	$2K
87015		<1%	334	$2K
J1953	Injection, levetiracetam, 10 mg	<1%	198	$2K
64494		<1%	971	$2K
72120		<1%	61	$2K
86301		<1%	167	$2K
76937		<1%	403	$2K
84432		<1%	75	$2K
90688		<1%	162	$2K
J0295	Injection, ampicillin sodium/sulbactam sodium, per 1.5 gm	<1%	1,090	$2K
80143		<1%	691	$2K
84305		<1%	164	$2K
82150		<1%	782	$2K
99454		<1%	16	$2K
82024		<1%	69	$2K
99204	Doctor's office visit, new patient (more involved)	<1%	28	$2K
36620		<1%	80	$2K
76706		<1%	15	$2K
91321		<1%	744	$2K
92588		<1%	17	$1K
J1790	Injection, droperidol, up to 5 mg	<1%	2,454	$1K
92556		<1%	15	$1K
85014		<1%	1,009	$1K
J2930	Injection, methylprednisolone sodium succinate, up to 125 mg	<1%	1,310	$1K
J2270	Injection, morphine sulfate, up to 10 mg	<1%	3,616	$1K
J3301	Injection, triamcinolone acetonide, not otherwise specified, 10 mg	<1%	19,656	$1K
J2272	Injection, morphine sulfate (fresenius kabi), not therapeutically equivalent to j2270, up to 10 mg	<1%	1,608	$1K
82232		<1%	141	$1K
00142		<1%	1,869	$1K
85384		<1%	275	$1K
76825		<1%	45	$1K
80175		<1%	170	$1K
85613		<1%	517	$1K
D1110	Prophylaxis - adult	<1%	13	$1K
82140		<1%	357	$1K
86663		<1%	130	$1K
Q2039	Influenza virus vaccine, not otherwise specified	<1%	1,458	$1K
82088		<1%	58	$1K
J1644	Injection, heparin sodium, per 1000 units	<1%	6,580	$1K
76827		<1%	45	$1K
84145		<1%	303	$1K
84207		<1%	193	$1K
84202		<1%	350	$1K
J1100	Injection, dexamethasone sodium phosphate, 1 mg	<1%	28,503	$1K
92552		<1%	163	$1K
83519		<1%	213	$1K
J3010	Injection, fentanyl citrate, 0.1 mg	<1%	38,099	$1K
A9575	Injection, gadoterate meglumine, 0.1 ml	<1%	4,248	$1K
74220		<1%	19	$1K
82270		<1%	501	$1K
29125		<1%	1,154	$1K
86618		<1%	183	$1K
96137		<1%	552	$1K
92652		<1%	19	$1K
82103		<1%	132	$1K
82390		<1%	222	$1K
J0690	Injection, cefazolin sodium, 500 mg	<1%	11,924	$1K
64636		<1%	24	$1K
00320		<1%	141	$1K
A4627	Spacer, bag or reservoir, with or without mask, for use with metered dose inhaler	<1%	369	$1K
J0171	Injection, adrenalin, epinephrine, 0.1 mg	<1%	4,753	$1K
J2405	Injection, ondansetron hydrochloride, per 1 mg	<1%	45,139	$1K
97016		<1%	28	$1K
G0481	Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms (any type, single or tandem and excluding immunoassays (e.g., ia, eia, elisa, emit, fpia) and enzymatic methods (e.g., alcohol dehydrogenase)), (2) stable isotope or other universally recognized internal standards in all samples (e.g., to control for matrix effects, interferences and variations in signal strength), and (3) method or drug-specific calibration and matrix-matched quality control material (e.g., to control for instrument variations and mass spectral drift); qualitative or quantitative, all sources, includes specimen validity testing, per day; 8-14 drug class(es), including metabolite(s) if performed	<1%	14	$988.81
J1071	Injection, testosterone cypionate, 1 mg	<1%	1,186	$968.91
82085		<1%	172	$966.59
83498		<1%	250	$961.91
86480		<1%	34	$927.08
80353		<1%	67	$922.05
87625		<1%	308	$919.58
H0048	Alcohol and/or other drug testing: collection and handling only, specimens other than blood	<1%	60	$902.64
84075		<1%	409	$896.47
00300		<1%	422	$890.35
0073A		<1%	61	$883.14
00140		<1%	70	$877.19
86664		<1%	130	$874.99
82164		<1%	94	$862.66
G0108	Diabetes outpatient self-management training services, individual, per 30 minutes	<1%	13	$842.20
J3411	Injection, thiamine hcl, 100 mg	<1%	1,154	$841.01
76818		<1%	18	$829.24
76942		<1%	1,713	$803.58
98927		<1%	13	$800.90
88173		<1%	770	$797.58
J2469	Injection, palonosetron hcl, 25 mcg	<1%	372	$790.83
96161		<1%	16	$779.03
A9500	Technetium tc-99m sestamibi, diagnostic, per study dose	<1%	1,213	$776.00
88184		<1%	26	$761.32
82397		<1%	125	$745.66
82375		<1%	398	$743.48
00812		<1%	819	$736.17
J7060	5% dextrose/water (500 ml = 1 unit)	<1%	4,503	$721.59
87102		<1%	83	$717.43
88185		<1%	49	$709.82
J2250	Injection, midazolam hydrochloride, per 1 mg	<1%	44,711	$683.44
J8540	Dexamethasone, oral, 0.25 mg	<1%	1,919	$665.66
A9552	Fluorodeoxyglucose f-18 fdg, diagnostic, per study dose, up to 45 millicuries	<1%	781	$657.00
72157		<1%	16	$647.14
J7510	Prednisolone oral, per 5 mg	<1%	493	$611.59
51702		<1%	404	$608.96
Q4010	Cast supplies, short arm cast, adult (11 years +), fiberglass	<1%	406	$605.96
H1003	Prenatal care, at-risk enhanced service; education	<1%	2,037	$593.63
84244		<1%	54	$587.49
80179		<1%	564	$574.67
J7050	Infusion, normal saline solution, 250 cc	<1%	7,496	$565.03
86902		<1%	109	$564.73
83014		<1%	50	$559.59
J7512	Prednisone, immediate release or delayed release, oral, 1 mg	<1%	7,510	$540.97
82668		<1%	65	$518.64
80074		<1%	47	$495.59
J2310	Injection, naloxone hydrochloride, per 1 mg	<1%	85	$494.19
83050		<1%	398	$470.75
86677		<1%	31	$463.83
84520		<1%	113	$463.38
G0009	Administration of pneumococcal vaccine	<1%	1,536	$461.86
64491		<1%	54	$453.43
J1805	Injection, esmolol hydrochloride, 10 mg	<1%	1,833	$442.35
G0103	Prostate cancer screening; prostate specific antigen test (psa)	<1%	365	$427.55
J2765	Injection, metoclopramide hcl, up to 10 mg	<1%	2,850	$419.12
96409		<1%	79	$409.74
85651		<1%	595	$403.42
J7620	Albuterol, up to 2.5 mg and ipratropium bromide, up to 0.5 mg, fda-approved final product, non-compounded, administered through dme	<1%	7,132	$398.73
72020		<1%	18	$393.39
86335		<1%	20	$383.12
J2175	Injection, meperidine hydrochloride, per 100 mg	<1%	4,622	$378.93
J0184	Injection, amisulpride, 1 mg	<1%	344	$377.51
A4614	Peak expiratory flow rate meter, hand held	<1%	431	$377.00
84300		<1%	142	$372.80
90660		<1%	39	$359.72
87075		<1%	379	$358.44
J2370	Injection, phenylephrine hcl, up to 1 ml	<1%	2,505	$350.43
J3250	Injection, trimethobenzamide hcl, up to 200 mg	<1%	57	$349.27
81240		<1%	18	$346.90
86146		<1%	68	$345.77
86317		<1%	34	$341.87
80299		<1%	26	$336.83
J0360	Injection, hydralazine hcl, up to 20 mg	<1%	724	$334.73
80202		<1%	40	$333.67
J3360	Injection, diazepam, up to 5 mg	<1%	491	$309.34
84590		<1%	49	$303.29
85007		<1%	508	$291.72
J1200	Injection, diphenhydramine hcl, up to 50 mg	<1%	4,461	$289.88
80156		<1%	76	$286.08
00790		<1%	323	$278.39
J0780	Injection, prochlorperazine, up to 10 mg	<1%	1,103	$276.29
46600		<1%	223	$273.54
91319		<1%	262	$273.25
89051		<1%	454	$266.62
93284		<1%	18	$266.31
J2919	Injection, methylprednisolone sodium succinate, 5 mg	<1%	651	$263.53
83835		<1%	16	$256.89
73100		<1%	48	$256.28
87101		<1%	70	$252.40
C1760	Closure device, vascular (implantable/insertable)	<1%	235	$252.12
29130		<1%	412	$251.02
86777		<1%	20	$250.74
J3370	Injection, vancomycin hcl, 500 mg	<1%	1,022	$247.99
88302		<1%	211	$235.47
95874		<1%	36	$231.99
80183		<1%	19	$215.17
69200		<1%	63	$213.83
A9541	Technetium tc-99m sulfur colloid, diagnostic, per study dose, up to 20 millicuries	<1%	109	$210.28
J2001	Injection, lidocaine hcl for intravenous infusion, 10 mg	<1%	26,121	$208.39
0144A		<1%	22	$208.26
99368		<1%	137	$205.00
88312		<1%	130	$204.80
88313		<1%	133	$204.53
87116		<1%	48	$203.95
87106		<1%	20	$201.00
J2360	Injection, orphenadrine citrate, up to 60 mg	<1%	607	$181.40
80185		<1%	36	$176.22
12031		<1%	13	$175.32
81241		<1%	18	$173.40
J1250	Injection, dobutamine hydrochloride, per 250 mg	<1%	33	$170.48
G0268	Removal of impacted cerumen (one or both ears) by physician on same date of service as audiologic function testing	<1%	163	$165.89
90649		<1%	16	$165.70
J3480	Injection, potassium chloride, per 2 meq	<1%	1,359	$164.47
86880		<1%	39	$162.10
G0010	Administration of hepatitis b vaccine	<1%	465	$160.89
J1940	Injection, furosemide, up to 20 mg	<1%	1,347	$156.86
J0461	Injection, atropine sulfate, 0.01 mg	<1%	224	$141.59
90473		<1%	255	$138.38
91300		<1%	14,213	$136.31
A6213	Foam dressing, wound cover, sterile, pad size more than 16 sq. in. but less than or equal to 48 sq. in., with any size adhesive border, each dressing	<1%	717	$135.96
J2371	Injection, phenylephrine hydrochloride, 20 micrograms	<1%	9,149	$129.25
82747		<1%	126	$122.75
98967		<1%	74	$119.80
90653		<1%	27	$118.29
J1631	Injection, haloperidol decanoate, per 50 mg	<1%	67	$116.61
80051		<1%	89	$114.58
36600		<1%	36	$114.58
J2060	Injection, lorazepam, 2 mg	<1%	884	$107.83
J1030	Injection, methylprednisolone acetate, 40 mg	<1%	690	$105.71
29505		<1%	302	$105.64
95909		<1%	32	$103.86
80047		<1%	74	$101.56
77417		<1%	120	$93.54
J1836	Injection, metronidazole, 10 mg	<1%	522	$88.76
J9190	Injection, fluorouracil, 500 mg	<1%	498	$80.60
87184		<1%	21	$80.18
J7613	Albuterol, inhalation solution, fda-approved final product, non-compounded, administered through dme, unit dose, 1 mg	<1%	5,062	$79.89
C2617	Stent, non-coronary, temporary, without delivery system	<1%	115	$79.54
94799		<1%	157	$79.20
96411		<1%	734	$77.34
J1580	Injection, garamycin, gentamicin, up to 80 mg	<1%	131	$73.97
Q0163	Diphenhydramine hydrochloride, 50 mg, oral, fda approved prescription anti-emetic, for use as a complete therapeutic substitute for an iv anti-emetic at time of chemotherapy treatment not to exceed a 48 hour dosage regimen	<1%	3,164	$71.31
Q4012	Cast supplies, short arm cast, pediatric (0-10 years), fiberglass	<1%	110	$67.56
J7042	5% dextrose/normal saline (500 ml = 1 unit)	<1%	165	$67.13
J0612	Injection, calcium gluconate, not otherwise specified, 10 mg	<1%	31	$61.74
J2785	Injection, regadenoson, 0.1 mg	<1%	994	$61.15
J1020	Injection, methylprednisolone acetate, 20 mg	<1%	2,078	$60.89
J2359	Injection, olanzapine, 0.5 mg	<1%	16	$59.47
J0665	Injection, bupivicaine, not otherwise specified, 0.5 mg	<1%	7,790	$56.77
83930		<1%	19	$54.86
J1040	Injection, methylprednisolone acetate, 80 mg	<1%	59	$54.76
J2003	Injection, lidocaine hydrochloride, 1 mg	<1%	2,782	$54.25
87350		<1%	13	$53.22
J2470	Injection, pantoprazole sodium, 40 mg	<1%	252	$52.57
96139		<1%	128	$49.74
J0330	Injection, succinylcholine chloride, up to 20 mg	<1%	1,495	$49.34
J1596	Injection, glycopyrrolate, 0.1 mg	<1%	2,623	$47.61
Q4038	Cast supplies, short leg cast, adult (11 years +), fiberglass	<1%	55	$46.00
J9267	Injection, paclitaxel, 1 mg	<1%	661	$45.81
J7644	Ipratropium bromide, inhalation solution, fda-approved final product, non-compounded, administered through dme, unit dose form, per milligram	<1%	436	$44.58
91318		<1%	15	$43.75
73010		<1%	12	$41.63
91301		<1%	4,300	$40.06
98968		<1%	14	$39.54
J1630	Injection, haloperidol, up to 5 mg	<1%	243	$39.42
88311		<1%	70	$37.14
86707		<1%	13	$36.34
J1920	Injection, labetalol hydrochloride, 5 mg	<1%	859	$34.94
51797		<1%	413	$33.23
84134		<1%	12	$29.11
J0689	Injection, cefazolin sodium (baxter), not therapeutically equivalent to j0690, 500 mg	<1%	831	$28.24
J0744	Injection, ciprofloxacin for intravenous infusion, 200 mg	<1%	198	$25.88
J0280	Injection, aminophyllin, up to 250 mg	<1%	15	$25.25
J1171	Injection, hydromorphone, 0.1 mg	<1%	573	$24.59
91312		<1%	3,885	$24.40
J2920	Injection, methylprednisolone sodium succinate, up to 40 mg	<1%	73	$22.85
91307		<1%	3,048	$22.09
J2004	Injection, lidocaine hcl with epinephrine, 1 mg	<1%	384	$20.84
D0272	Bitewings - two radiographic images	<1%	132	$18.78
J1010	Injection, methylprednisolone acetate, 1 mg	<1%	381	$18.28
A4620	Variable concentration mask	<1%	2,579	$16.11
89060		<1%	14	$14.62
J0456	Injection, azithromycin, 500 mg	<1%	98	$13.33
91305		<1%	2,016	$10.09
83935		<1%	12	$9.74
90611		<1%	185	$8.53
J2300	Injection, nalbuphine hydrochloride, per 10 mg	<1%	14	$7.17
A6219	Gauze, non-impregnated, sterile, pad size 16 sq. in. or less, with any size adhesive border, each dressing	<1%	1,271	$7.07
91311		<1%	841	$6.24
J2305	Injection, nitroglycerin, 5 mg	<1%	132	$5.92
J2795	Injection, ropivacaine hydrochloride, 1 mg	<1%	1,133	$4.62
91315		<1%	435	$3.72
C1769	Guide wire	<1%	1,761	$3.16
92025		<1%	27	$2.65
A6222	Gauze, impregnated with other than water, normal saline, or hydrogel, sterile, pad size 16 sq. in. or less, without adhesive border, each dressing	<1%	2,087	$2.33
92060		<1%	127	$2.29
91313		<1%	300	$1.91
91316		<1%	130	$1.24
91303		<1%	81	$0.76
91314		<1%	35	$0.06
Q9966	Low osmolar contrast material, 200-299 mg/ml iodine concentration, per ml	<1%	879	$0.04
G1003	Clinical decision support mechanism medicalis, as defined by the medicare appropriate use criteria program	<1%	815	$0.03
00813		0%	736	$0.00
C1725	Catheter, transluminal angioplasty, non-laser (may include guidance, infusion/perfusion capability)	0%	613	$0.00
01214		0%	108	$0.00
G0432	Infectious agent antibody detection by enzyme immunoassay (eia) technique, hiv-1 and/or hiv-2, screening	0%	43	$0.00
C1819	Surgical tissue localization and excision device (implantable)	0%	386	$0.00
00952		0%	245	$0.00
77001		0%	278	$0.00
00126		0%	14	$0.00
01480		0%	492	$0.00
A6223	Gauze, impregnated with other than water, normal saline, or hydrogel, sterile, pad size more than 16 sq. in., but less than or equal to 48 sq. in., without adhesive border, each dressing	0%	42	$0.00
36410		0%	28	$0.00
96377		0%	69	$0.00
29540		0%	161	$0.00
01400		0%	46	$0.00
00160		0%	12	$0.00
C1726	Catheter, balloon dilatation, non-vascular	0%	61	$0.00
A9503	Technetium tc-99m medronate, diagnostic, per study dose, up to 30 millicuries	0%	25	$0.00
D0240		0%	62	$0.00
C1781	Mesh (implantable)	0%	111	$0.00
00190		0%	16	$0.00
86812		0%	13	$0.00
64484		0%	12	$0.00
C1729	Catheter, drainage	0%	462	$0.00
77387		0%	93	$0.00
29530		0%	386	$0.00
00910		0%	236	$0.00
01810		0%	770	$0.00
00732		0%	16	$0.00
C1751	Catheter, infusion, inserted peripherally, centrally or midline (other than hemodialysis)	0%	288	$0.00
C1887	Catheter, guiding (may include infusion/perfusion capability)	0%	653	$0.00
01830		0%	365	$0.00
01402		0%	224	$0.00
86703		0%	106	$0.00
C1894	Introducer/sheath, other than guiding, other than intracardiac electrophysiological, non-laser	0%	1,407	$0.00
C1758	Catheter, ureteral	0%	86	$0.00
96381		0%	15	$0.00
Q0144	Azithromycin dihydrate, oral, capsules/powder, 1 gram	0%	167	$0.00
99001		0%	12	$0.00
G8978	Mobility: walking & moving around functional limitation, current status, at therapy episode outset and at reporting intervals	0%	33	$0.00
G0500	Moderate sedation services provided by the same physician or other qualified health care professional performing a gastrointestinal endoscopic service that sedation supports, requiring the presence of an independent trained observer to assist in the monitoring of the patient's level of consciousness and physiological status; initial 15 minutes of intra-service time; patient age 5 years or older (additional time may be reported with 99153, as appropriate)	0%	56	$0.00
76376		0%	99	$0.00
92100		0%	42	$0.00
H1002	Prenatal care, at risk enhanced service; care coordination	0%	1,279	$0.00
G8979	Mobility: walking & moving around functional limitation, projected goal status, at therapy episode outset, at reporting intervals, and at discharge or to end reporting	0%	80	$0.00
J2710	Injection, neostigmine methylsulfate, up to 0.5 mg	0%	18	$0.00
75565		0%	16	$0.00
J7614	Levalbuterol, inhalation solution, fda-approved final product, non-compounded, administered through dme, unit dose, 0.5 mg	0%	12	$0.00
01844		0%	19	$0.00
00920		0%	39	$0.00
C1788	Port, indwelling (implantable)	0%	17	$0.00
J3473	Injection, hyaluronidase, recombinant, 1 usp unit	0%	14	$0.00
J2720	Injection, protamine sulfate, per 10 mg	0%	46	$0.00
00402		0%	13	$0.00
0141A		0%	12	$0.00
L3908	Wrist hand orthosis, wrist extension control cock-up, non molded, prefabricated, off-the-shelf	0%	16	$0.00
93321		0%	31	$0.00
51703		0%	12	$0.00

Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.

From NPPES

Who's on the registration

Authorized officialHOLLINGS, DERRICK (EVP/CFO)

Parent organizationTHE METROHEALTH SYSTEM

Same official

Other billing entities under HOLLINGS, DERRICK

Full network →

Provider	Location	Paid
The Metrohealth System	Cleveland, OH	$125.46M
The Metrohealth System	Cleveland, OH	$27.31M
The Metrohealth System	Cleveland, OH	$7.81M
The Metrohealth System	Cleveland, OH	$1.46M
The Metrohealth System	Cleveland, OH	$991K
Hennepin Healthcare Systems, INC.	Minneapolis, MN	$257K
The Metrohealth System	Cleveland, OH	$375.56

Matched on the authorized-official name exactly as entered in NPPES. A common name can match unrelated people.